| WHO | World Health Organization |
| GC-MS | Gas Chromatography Mass Spectrometry |
| HPLC | High-performance liquid chromatography |
| TLC | Thin-Layer Chromatography |
| LC-MS | Liquid Chromatography–Mass Spectrometry |
| ROS | Reactive Oxygen Species |
| IL | Interleukin |
| TNF | Tumor Necrosis Factor |
| LPS | Lipopolysaccharide |
| NOS | Nitric Oxide Synthase |
| COX-2 | Cyclooxygenase 2 |
| NO | Nitric Oxide |
| PGE-2 | Prostaglandin E2 |
| NF-κB | Nuclear Factor kappa B |
| AP-1 | Activator Protein 1 |
| JNK | c-Jun N-terminal Kinase |
| MAPK | Mitogen-Activated Protein Kinase |
| FXR | Farnesoid X Receptor |
| Nrf2 | Nuclear Factor Erythroid 2-related Factor 2 |
| D-GaIN | D-galactosamine |
| AchE | Acetylcholinesterase |
| MAO | Monoamine oxidase |
| 5-HT | Serotonin |
| NMDA | N-Methyl-D-aspartate |
| GABA | γ-aminobutyric Acid |
| GAD | Generalized Anxiety Disorder |
| SSRI | Selective Serotonin Reuptake Inhibitor |
| NNK | 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone |
| B[a]P | Benzo[a]pyrene |
| DHM | Dihydromethysticin |
| DHK | Dihydrokavain |
| AhR | Aryl Hydrocarbon Receptor |
| NNAL | 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol |
| CYP2A5 | Cytochrome P450 2A5 |
| UCC | Urothelial cell carcinoma |
| TRAMP | Transgenic Adenocarcinoma of Mouse Prostate |
| Skp2 | S phase Kinase-associated Protein 2 |
| NECa | Neuroendocrine Carcinomas |
| AR | Androgen Receptor |
| NSCLC | Non-Small Cell Lung Cancer |
| UCK2 | Uridine-Cytidine Kinase 2 |
| XIAP | X-Linked Inhibitor of Apoptosis |
| FDA | Food and Drug Administration |
| ALT | Alanine Transaminase |
| AST | Aspartate transaminase |
| GGT | Gamma-glutamyltransferase |
| NTP | National Toxicology Program |
| BZD | Benzodiazepine |
| CIOMS | Council for International Organizations of Medical Sciences |
| ALP | Alkaline phosphatase |
| CAERS | CFSAN Adverse Event Reporting System |
| ADME | Absorption, distribution, metabolism, and excretion |
| CFSAN | Center for Food Safety and Applied Nutrition |
| QC | Quality control |